News

February 17th, 2025

Stardots finalist in the Entrepreneurs Future Forecast of the Year.

February 6th, 2025

PM – Stardots includes first subject in clinical trial of ANLIVA® in the U.S.

February 6th, 2025

ANLIVA Eye Movement as a potential digital biomarker

February 5th, 2025

Stardots Shines in Industrifonden’s Latest Deep Tech Funding Report

February 5th, 2025

Stardots to initiate clinical study of ANLIVA DBS in Parkinson’s disease patients in collaboration with Dartmouth Hitchcock Medical Center

January 29th, 2025

ANLIVA Hand Movement – standardizing care for patients with motor symptoms

January 22nd, 2025

Automizing deep brain stimulation for Parkinson’s Disease

September 18th, 2024

Stardots starts Clinical Trials in the USA

September 18th, 2024

Stardots at Bio-X

September 5th, 2024

Stardots Welcomes Mikael Andén to Board of Directors

Next page

Stay up-to-date

Sign up to receive updates on our latest developments.